Endo Revenue and Competitors
Estimated Revenue & Valuation
- Endo's estimated annual revenue is currently $3B per year.
- Endo's estimated revenue per employee is $2,094,834
- Endo's total funding is $295M.
- Endo's current valuation is $764.1M. (January 2022)
Employee Data
- Endo has 1413 Employees.
- Endo grew their employee count by -4% last year.
Endo's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Executive Director, Customer Service and Operations | Reveal Email/Phone |
2 | Senior Manager, Quality Operations | Reveal Email/Phone |
3 | Support Analyst | Reveal Email/Phone |
4 | Accounts Payable Associate II | Reveal Email/Phone |
5 | Director, QA Generic Products | Reveal Email/Phone |
6 | Lab Manager (R&D) | Reveal Email/Phone |
7 | Operations Supervisor | Reveal Email/Phone |
8 | Aesthetics Consumer Marketing Director | Reveal Email/Phone |
9 | VP Global ERP Systems & Technology | Reveal Email/Phone |
10 | Specialty Sales Consultant | Reveal Email/Phone |
Endo Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Endo?
Endo Pharmaceuticals is a fully integrated specialty pharmaceutical company with market leadership in pain management products. The company researches, develops, produces and markets a broad product offering of both branded and generic pharmaceuticals, meeting the needs of healthcare professionals and consumers alike.
keywords:N/A
$295M
Total Funding
1413
Number of Employees
$3B
Revenue (est)
-4%
Employee Growth %
$764.1M
Valuation
N/A
Accelerator
Endo News
Endo Pharmaceuticals (NASDAQ:ENDP) has agreed to pay the city of San Francisco $10M over its role in the sale of prescription opioids in the...
Law360 (April 20, 2022, 11:01 PM EDT) -- Endo Pharmaceuticals has agreed to pay $10 million over the course of 10 years to resolve the city of San...
Endo makes the opioid painkiller Percocet, but has not marketed the drug since 2016. Endo, which did not admit wrongdoing in the settlement,...
Other Companies in Malvern
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $587.6M | 1713 | 6% | N/A |
#2 | $781M | 1774 | 3% | N/A |
#3 | $750M | 3294 | N/A | N/A |
#4 | $1167.9M | 3405 | 10% | N/A |
#5 | $750M | 3537 | 4% | N/A |